| Kristin Marie Fulkerson, MD | |
|
1401 E H St, Mc Cook, NE 69001-3589 | |
| (308) 344-4110 | |
| (308) 344-8369 |
| Full Name | Kristin Marie Fulkerson |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 17 Years |
| Location | 1401 E H St, Mc Cook, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174701239 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 24897 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Healthcare And Hospice | Mccook, NE | Home health agency |
| Community Health Care & Hospice | Mccook, NE | Hospice |
| Community Hospital | Mccook, NE | Hospital |
| The Nebraska Medical Center | Omaha, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mccook Clinic, P.c. | 0941196125 | 12 |
News Archive
Highly-caffeinated energy drinks - even those containing no alcohol - may pose a significant threat to individuals and public health, say researchers at the University of Maryland School of Public Health and Wake Forest University School of Medicine.
Scientists are reporting discovery of a potential new drug for epidemic keratoconjunctivitis (EKC) - sometimes called "pink eye" - a highly infectious eye disease that may occur in 15 million to 20 million people annually in the United States alone. Their report describing an innovative new "molecular wipe" that sweeps up viruses responsible for EKC appears in ACS's Journal of Medicinal Chemistry.
A new treatment option for Canadians with schizophrenia, ABILIFY(TM) (aripiprazole), is now available in Canada. For those living with this lifelong disease who may be struggling with a treatment that doesn't work for them or with side effects that are difficult to tolerate, ABILIFY offers efficacy and good safety and tolerability with limited impact on weight, blood sugar and lipids - significant clinical benefits that may help patients stay on treatment longer.
If you're a baby boomer, you may not know that odds are high that you're carrying the hepatitis C virus, putting yourself at risk for illness that can range from minor to life threatening.
A preliminary study by researchers from the Garvan Institute of Medical Research and the University of New South Wales and published on the preprint server bioRxiv in June 2020 reports the use of chimeric design to produced reference standards for diagnostic tests. This could allow a highly flexible approach to the development of different genetic features in the same test, even for organisms that are not directly related.
› Verified 7 days ago
| Entity Name | Mccook Clinic, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336290972 PECOS PAC ID: 0941196125 Enrollment ID: O20040225000128 |
News Archive
Highly-caffeinated energy drinks - even those containing no alcohol - may pose a significant threat to individuals and public health, say researchers at the University of Maryland School of Public Health and Wake Forest University School of Medicine.
Scientists are reporting discovery of a potential new drug for epidemic keratoconjunctivitis (EKC) - sometimes called "pink eye" - a highly infectious eye disease that may occur in 15 million to 20 million people annually in the United States alone. Their report describing an innovative new "molecular wipe" that sweeps up viruses responsible for EKC appears in ACS's Journal of Medicinal Chemistry.
A new treatment option for Canadians with schizophrenia, ABILIFY(TM) (aripiprazole), is now available in Canada. For those living with this lifelong disease who may be struggling with a treatment that doesn't work for them or with side effects that are difficult to tolerate, ABILIFY offers efficacy and good safety and tolerability with limited impact on weight, blood sugar and lipids - significant clinical benefits that may help patients stay on treatment longer.
If you're a baby boomer, you may not know that odds are high that you're carrying the hepatitis C virus, putting yourself at risk for illness that can range from minor to life threatening.
A preliminary study by researchers from the Garvan Institute of Medical Research and the University of New South Wales and published on the preprint server bioRxiv in June 2020 reports the use of chimeric design to produced reference standards for diagnostic tests. This could allow a highly flexible approach to the development of different genetic features in the same test, even for organisms that are not directly related.
› Verified 7 days ago
| Entity Name | Community Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588771158 PECOS PAC ID: 9133101629 Enrollment ID: O20040607001378 |
News Archive
Highly-caffeinated energy drinks - even those containing no alcohol - may pose a significant threat to individuals and public health, say researchers at the University of Maryland School of Public Health and Wake Forest University School of Medicine.
Scientists are reporting discovery of a potential new drug for epidemic keratoconjunctivitis (EKC) - sometimes called "pink eye" - a highly infectious eye disease that may occur in 15 million to 20 million people annually in the United States alone. Their report describing an innovative new "molecular wipe" that sweeps up viruses responsible for EKC appears in ACS's Journal of Medicinal Chemistry.
A new treatment option for Canadians with schizophrenia, ABILIFY(TM) (aripiprazole), is now available in Canada. For those living with this lifelong disease who may be struggling with a treatment that doesn't work for them or with side effects that are difficult to tolerate, ABILIFY offers efficacy and good safety and tolerability with limited impact on weight, blood sugar and lipids - significant clinical benefits that may help patients stay on treatment longer.
If you're a baby boomer, you may not know that odds are high that you're carrying the hepatitis C virus, putting yourself at risk for illness that can range from minor to life threatening.
A preliminary study by researchers from the Garvan Institute of Medical Research and the University of New South Wales and published on the preprint server bioRxiv in June 2020 reports the use of chimeric design to produced reference standards for diagnostic tests. This could allow a highly flexible approach to the development of different genetic features in the same test, even for organisms that are not directly related.
› Verified 7 days ago
| Entity Name | Community Hospital Association |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1841204500 PECOS PAC ID: 9133101629 Enrollment ID: O20100908000859 |
News Archive
Highly-caffeinated energy drinks - even those containing no alcohol - may pose a significant threat to individuals and public health, say researchers at the University of Maryland School of Public Health and Wake Forest University School of Medicine.
Scientists are reporting discovery of a potential new drug for epidemic keratoconjunctivitis (EKC) - sometimes called "pink eye" - a highly infectious eye disease that may occur in 15 million to 20 million people annually in the United States alone. Their report describing an innovative new "molecular wipe" that sweeps up viruses responsible for EKC appears in ACS's Journal of Medicinal Chemistry.
A new treatment option for Canadians with schizophrenia, ABILIFY(TM) (aripiprazole), is now available in Canada. For those living with this lifelong disease who may be struggling with a treatment that doesn't work for them or with side effects that are difficult to tolerate, ABILIFY offers efficacy and good safety and tolerability with limited impact on weight, blood sugar and lipids - significant clinical benefits that may help patients stay on treatment longer.
If you're a baby boomer, you may not know that odds are high that you're carrying the hepatitis C virus, putting yourself at risk for illness that can range from minor to life threatening.
A preliminary study by researchers from the Garvan Institute of Medical Research and the University of New South Wales and published on the preprint server bioRxiv in June 2020 reports the use of chimeric design to produced reference standards for diagnostic tests. This could allow a highly flexible approach to the development of different genetic features in the same test, even for organisms that are not directly related.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristin Marie Fulkerson, MD 71882 Pietro Dr, Mc Cook, NE 69001-7279 Ph: (712) 308-6820 | Kristin Marie Fulkerson, MD 1401 E H St, Mc Cook, NE 69001-3589 Ph: (308) 344-4110 |
News Archive
Highly-caffeinated energy drinks - even those containing no alcohol - may pose a significant threat to individuals and public health, say researchers at the University of Maryland School of Public Health and Wake Forest University School of Medicine.
Scientists are reporting discovery of a potential new drug for epidemic keratoconjunctivitis (EKC) - sometimes called "pink eye" - a highly infectious eye disease that may occur in 15 million to 20 million people annually in the United States alone. Their report describing an innovative new "molecular wipe" that sweeps up viruses responsible for EKC appears in ACS's Journal of Medicinal Chemistry.
A new treatment option for Canadians with schizophrenia, ABILIFY(TM) (aripiprazole), is now available in Canada. For those living with this lifelong disease who may be struggling with a treatment that doesn't work for them or with side effects that are difficult to tolerate, ABILIFY offers efficacy and good safety and tolerability with limited impact on weight, blood sugar and lipids - significant clinical benefits that may help patients stay on treatment longer.
If you're a baby boomer, you may not know that odds are high that you're carrying the hepatitis C virus, putting yourself at risk for illness that can range from minor to life threatening.
A preliminary study by researchers from the Garvan Institute of Medical Research and the University of New South Wales and published on the preprint server bioRxiv in June 2020 reports the use of chimeric design to produced reference standards for diagnostic tests. This could allow a highly flexible approach to the development of different genetic features in the same test, even for organisms that are not directly related.
› Verified 7 days ago
Corinne Phillips-ward, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1401 E H St, Mc Cook, NE 69001 Phone: 308-344-4110 Fax: 308-344-8369 | |
John West, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1401 E H St, Mc Cook, NE 69001 Phone: 308-344-4110 Fax: 308-344-8369 | |
Richard Klug, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1401 E H St, Mc Cook, NE 69001 Phone: 308-344-4110 Fax: 308-344-8369 | |
Dr. Hope Ann Ferguson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1401 E H St, Mc Cook, NE 69001 Phone: 308-344-8784 Fax: 308-344-8780 | |
Jason J Blomstedt, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1401 E H St, Mc Cook, NE 69001 Phone: 308-344-4110 Fax: 308-344-8369 | |
Dr. Matthew Nielsen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1401 E H St, Mc Cook, NE 69001 Phone: 308-344-4110 |